InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score43
United States Fiscal year ends December CIK 0001583648 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

43
Insider
Date
Role
Action
Shares
Price
Amount
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
607
$126.19
$76.60K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
1,663
$125.16
$208.15K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
2,043
$123.62
$252.56K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
1,654
$153.24
$253.46K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
989
$152.36
$150.69K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
1,659
$151.16
$250.77K
Christopher P Kiritsy
2 Sep 2026
Director
Sold after exercise
313
$157.00
$49.14K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
302
$156.77
$47.34K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
102
$155.59
$15.87K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
400
$153.00
$61.20K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
1,998
$151.80
$303.29K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
1,500
$151.39
$227.09K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
1,911
$150.25
$287.13K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
1,029
$149.27
$153.60K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
840
$148.40
$124.66K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
522
$147.14
$76.81K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
25
$112.23
$2.81K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
1,887
$111.31
$210.05K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
2,390
$110.26
$263.52K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
48
$111.90
$5.37K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
891
$111.30
$99.17K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
3,363
$110.35
$371.09K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
100
$130.33
$13.03K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
639
$129.17
$82.54K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
561
$128.23
$71.94K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
1,500
$127.13
$190.69K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
1,502
$125.96
$189.20K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
304
$119.08
$36.20K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
1,730
$118.37
$204.78K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
2,268
$117.56
$266.63K
Kathleen Goin
18 Feb 2026
Chief Operating Officer
Sold after exercise
1,276
$79.97
$102.04K
Kathleen Goin
18 Feb 2026
Chief Operating Officer
Sold after exercise
3,026
$79.16
$239.53K
Kathleen Goin
21 Jan 2026
Chief Operating Officer
Sold after exercise
3,749
$97.94
$367.18K
Kathleen Goin
21 Jan 2026
Chief Operating Officer
Sold after exercise
553
$95.49
$52.81K
Kathleen Goin
17 Dec 2025
Chief Operating Officer
Sold after exercise
4,302
$96.47
$415.02K
Kathleen Goin
19 Nov 2025
Chief Operating Officer
Sold after exercise
2,802
$86.51
$242.39K
Kathleen Goin
19 Nov 2025
Chief Operating Officer
Sold after exercise
1,500
$85.72
$128.58K
Shane Olwill
30 Aug 2021
Chief Development Officer
Sold after exercise
29,200
$5.15
$150.38K
Shane Olwill
30 Aug 2021
Chief Development Officer
Sold after exercise
9,200
$5.00
$46.00K
Orbimed Advisors LLC
13 Feb 2018
10% owner
Sold after exercise indirect
75
$8.98
$673.50
Orbimed Advisors LLC
13 Feb 2018
10% owner
Sold after exercise indirect
7,822
$8.98
$70.24K
Orbimed Advisors LLC
18 Dec 2017
10% owner
Sold after exercise indirect
1,392
$5.70
$7.93K
Orbimed Advisors LLC
18 Dec 2017
10% owner
Sold after exercise indirect
146,243
$5.70
$833.59K
Show all 96 transactions →

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 43
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 5,690,810
Sales filed before the plan box existed 8
History held since 8 Jul 2015